A Multicenter, Randomized, Double-blind, Parallel, Placebo-controlled Phase II Clinical Study to Evaluate the Efficacy of Mosapride Citrate Injection in the Treatment of Postoperative Gastrointestinal Dysfunction
Latest Information Update: 29 Jan 2025
Price :
$35 *
At a glance
- Drugs Mosapride (Primary)
- Indications Gastrointestinal disorders; Gastrointestinal motility disorders
- Focus Therapeutic Use
- Sponsors Shandong New Time Pharmaceutical Co LTD
- 29 Jan 2025 New trial record